J

A

JAFFRE , A.

Last name: JAFFRE

First name: A.

June 3, 2024 (v1)

Journal article

Metadata-only

Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018)

Courtinard, C. Barbet, V. Schiappa, R.

Background: Real-world data (RWD) can contextualize clinical trial data. We present real-world evidence thatsupplemented the single-arm DESTINY-Breast01 trial, which assessed the efficacy and safety of trastuzumabderuxtecan (T-DXd) in patients with human epidermal growth factor receptor 2-positive (HER2þ) metastatic breastcancer (mBC)...

Uploaded on: August 13, 2024